These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


160 related items for PubMed ID: 310340

  • 1. In vitro induction of Lyt surface markers on precursor cells incubated with thymosin polypeptides.
    Ahmed A, Smith AH, Wong DM, Thurman GB, Goldstein AL, Sell KW.
    Cancer Treat Rep; 1978 Nov; 62(11):1739-47. PubMed ID: 310340
    [Abstract] [Full Text] [Related]

  • 2. Control of differentiation of thymocyte precursors in the bone marrow by thymic hormones.
    Pazmiño NH, Ihle JN, McEwan RN, Goldstein AL.
    Cancer Treat Rep; 1978 Nov; 62(11):1749-55. PubMed ID: 310341
    [Abstract] [Full Text] [Related]

  • 3. In vivo generation of suppressor T cells by thymosin in congenitally athymic nude mice.
    Marshall GD, Thurman GB, Rossio JL, Goldstein AL.
    J Immunol; 1981 Feb; 126(2):741-4. PubMed ID: 6161188
    [Abstract] [Full Text] [Related]

  • 4. Induction of terminal deoxynucleotidyl transferase and Lyt antigens with thymosin: identification of multiple subsets of prothymocytes in mouse bone marrow and spleen.
    Goldschneider I, Ahmed A, Bollum FJ, Goldstein AL.
    Proc Natl Acad Sci U S A; 1981 Apr; 78(4):2469-73. PubMed ID: 6972536
    [Abstract] [Full Text] [Related]

  • 5. [Modulation of suppressor activity by thymosin].
    Cupissol D, Thierry C, Serrou B.
    C R Seances Soc Biol Fil; 1981 Apr; 175(2):235-41. PubMed ID: 6454471
    [Abstract] [Full Text] [Related]

  • 6. Manifestation and growth of a transplantable osteosarcoma in mice: the effects of thymectomy and thymosin treatment.
    Carlsson SR, Stigbrand T, Boquist L, Lundgren E, Winblad B, Larsson SE.
    Clin Orthop Relat Res; 1981 Sep; (159):279-85. PubMed ID: 6974629
    [Abstract] [Full Text] [Related]

  • 7. [Thymosin activation of T-killer precursors for hematopoietic stem cells].
    Chermeneva LM, Arion VIa, Gladysheva TV, Petrov RV, Khaitov RM.
    Biull Eksp Biol Med; 1978 May; 85(5):602-5. PubMed ID: 306843
    [Abstract] [Full Text] [Related]

  • 8. In vitro effects of two immunopotentiators, Isoprinosine and NPT 15392, on murine T-cell differentiation and function.
    Ikehara S, Hadden JW, Good RA, Lunzer DG, Pahwa RN.
    Thymus; 1981 Aug; 3(2):87-95. PubMed ID: 6170135
    [Abstract] [Full Text] [Related]

  • 9. Overview of thymosin activity.
    Marshall GD, Low TL, Thurman GB, Hu SK, Rossio JL, Trivers G, Goldstein AL.
    Cancer Treat Rep; 1978 Nov; 62(11):1731-7. PubMed ID: 215305
    [Abstract] [Full Text] [Related]

  • 10. Enhancement of murine thymocyte cytotoxic T cell responses by thymosin.
    Zatz MM, Goldstein AL.
    Immunopharmacology; 1983 Jun; 6(1):65-74. PubMed ID: 6603447
    [Abstract] [Full Text] [Related]

  • 11. Thymosin-induced recovery of murine T-cell functions following treatment with hydrocortisone acetate.
    Thurman GB, Rossio JL, Goldstein AL.
    Transplant Proc; 1977 Mar; 9(1):1201-3. PubMed ID: 301305
    [No Abstract] [Full Text] [Related]

  • 12. [Factors controlling the recirculation of hematopoietic stem cells. IV. The effect of thymosin on the migration and differentiation of hematopoietic stem cells].
    Khaitov RM, Chermeneva LM, Riabova LV.
    Tsitologiia; 1979 Sep; 21(9):1058-64. PubMed ID: 505578
    [Abstract] [Full Text] [Related]

  • 13. Experiences with thymosin in primary immunodeficiency disease.
    Astaldi A, Astaldi GC, Wijermans P, Dagna-Bricarelli F, Kater L, Stoop JW, Vossen JM.
    Cancer Treat Rep; 1978 Nov; 62(11):1779-85. PubMed ID: 215306
    [Abstract] [Full Text] [Related]

  • 14. Decrease of tumor growth in mice after intravenous thymosin-treated bone marrow cell injection.
    Cupissol D, Rey A, Goldstein AL, Serrou B.
    J Natl Cancer Inst; 1982 Jul; 69(1):27-31. PubMed ID: 7047833
    [Abstract] [Full Text] [Related]

  • 15. T-lymphocyte maturation: cell surface markers and immune function induced by T-lymphocyte cell-free products and thymosin polypeptides.
    Ahmed A, Wong DM, Thurman GB, Low TL, Goldstein AL, Sharkis SJ, Goldschneider I.
    Ann N Y Acad Sci; 1979 Jul; 332():81-94. PubMed ID: 316987
    [No Abstract] [Full Text] [Related]

  • 16. Modulation of chronic lymphocytic leukemia (CLL) lymphocyte phenotypes by in vitro incubation with alpha 1 thymosin.
    Benković B, Burek B, Jaksić B, Vitale B.
    Blood Cells; 1987 Jul; 12(2):441-55. PubMed ID: 3304472
    [Abstract] [Full Text] [Related]

  • 17. Characterization of thymosin-responsive peripheral blood null cells.
    Kaplan J.
    Cancer Treat Rep; 1978 Nov; 62(11):1757-61. PubMed ID: 310342
    [Abstract] [Full Text] [Related]

  • 18. [Thymosin fraction 5. Preclinical study].
    Panajotovová V, Lastovicka J, Sůla K, Nouza K, Pokorná D, Grimová J.
    Cas Lek Cesk; 1989 Dec 15; 128(51):1615-20. PubMed ID: 2632000
    [Abstract] [Full Text] [Related]

  • 19. Regulation of in vitro generation of cell-mediated cytotoxicity. In vitro induction of suppressor T lymphocytes by thymosin.
    Marshall GD, Thurman GB, Goldstein AL.
    J Reticuloendothel Soc; 1980 Aug 15; 28(2):141-9. PubMed ID: 6447785
    [No Abstract] [Full Text] [Related]

  • 20. [Thymic hormonal effects on the antigen-dependent differentiation of accessory T-lymphocytes in the humoral immune response].
    Sobolev SM, Stepanova TN.
    Ontogenez; 1986 Aug 15; 17(1):62-9. PubMed ID: 3960463
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 8.